Endurant Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Endurant Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,590	Closed	-$2.71M	–	78
2020 Q4	$2.71M	Buy	+21,590	New	+$2.41M	0.98%	35
2020 Q2	–	Sell	-38,817	Closed	-$3.22M	–	75
2020 Q1	$3.22M	Sell	38,817 -20,166	-34%	-$1.97M	1.46%	19
2019 Q4	$6.56M	Sell	58,983 -67,826	-53%	-$6.98M	2.07%	16
2019 Q3	$12.6M	Buy	126,809 +29,609	+30%	+$2.94M	4.52%	9
2019 Q2	$9.64M	Buy	+97,200	New	+$9.28M	3.8%	7
2018 Q3	–	Sell	-15,068	Closed	-$1.41M	–	89
2018 Q2	$1.41M	Buy	+15,068	New	+$1.3M	0.61%	40

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Endurant Capital Management's PRAH Position: Q1 2021 in Review

Endurant Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 21,590 shares — an estimated $2.71M sold.

Endurant Capital Management first reported a position in PRAH in Q2 2018 and held it in 6 quarters. The position peaked at $12.6M in Q3 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

Endurant Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
Endurant Capital Management sold 21,590 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $2.71M.
Endurant Capital Management first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 6 quarters.
Endurant Capital Management's PRA Health Sciences, Inc. position peaked at $12.6M in Q3 2019.
324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Endurant Capital Management's 13F filing for Q1 2021, filed 17 May 2021.